Related Experiment Video
Updated: Aug 8, 2025

10:56
Procurement and Perfusion-Decellularization of Porcine Vascularized Flaps in a Customized Perfusion Bioreactor
Published on: August 1, 2022
2.8K
Decellularized Scaffold-Based Artificial Vascular Patch for Porcine Vascular Repair.
Cheng Liu1, Huimin Gao2, Gaoqi Sun2
1Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
ACS Applied Bio Materials
|March 6, 2023
Summary
This study developed a novel artificial vascular patch using decellularized scaffolds (DCS) coated with APZI-PVA hydrogel and MOF-Hep. The enhanced vascular patch improved cell adhesion and maintained patency in porcine carotid arteries, offering a promising solution for cardiovascular disease treatment.
Area of Science:
- Biomaterials Science
- Cardiovascular Research
- Tissue Engineering
Background:
- Cardiovascular diseases (CVD) necessitate effective vascular repair strategies.
- Artificial vascular patches are in high global demand.
- Decellularized scaffolds (DCS) offer a promising base for vascular grafts.
Purpose of the Study:
- To design and evaluate a multifunctional decellularized scaffold (DCS)-based vascular patch for porcine vascular repair.
- To enhance mechanical properties, biocompatibility, and hemocompatibility of the artificial vascular patch.
- To assess the potential of the vascular patch in promoting endothelialization and maintaining vascular patency.
Main Methods:
- Coating DCS with ammonium phosphate zwitter-ion (APZI) and poly(vinyl alcohol) (PVA) hydrogel.
- Decorating the surface with heparin (Hep)-loaded metal-organic framework (MOF).
- Evaluating mechanical properties, biocompatibility, blood compatibility, endothelial progenitor cell (EPC) adhesion and proliferation, and in vivo patency using B-ultrasound and CT imaging in a porcine carotid artery model.
Main Results:
- The MOF-Hep/APZI-PVA/DCS vascular patch exhibited suitable mechanical properties, good biocompatibility, and hemocompatibility.
- Enhanced proliferation and adhesion of EPCs were observed on the modified patch compared to unmodified PVA/DCS.
- In vivo implantation in porcine carotid arteries demonstrated maintained patency, confirmed by B-ultrasound and CT imaging.
Conclusions:
- The developed MOF-Hep/APZI-PVA/DCS vascular patch is a promising biomaterial for vascular replacement.
- The multifunctional coating effectively improves the performance of DCS-based vascular grafts.
- This artificial vascular patch shows significant potential for treating cardiovascular diseases by promoting vascular repair and function.

